Cancer Biology & Medicine is a peer-reviewed english-language open-access journal published by China Anti-Cancer Association in China, operating under an open-access model since 2012. The journal covers Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens.
Authors are required to pay an article processing charge to publish in Cancer Biology & Medicine; refer to the journal's APC page for the current rate. Articles are released under the CC BY-NC license (see other journals using this license).
To date, Cancer Biology & Medicine has published 880 articles. Articles are minted with DOIs through the prefix 10.20892.
Keywords
cancer genetics, oncology clinical trials, targeted therapy and immunology, cancer and stem cell biology, cancer prevention and epidemiology, cancer biomarkers
At a glance
- Publisher
- China Anti-Cancer Association
- Country
- China
- Primary language
- English
- License
- CC BY-NC
- Peer review
- Peer review
- OA since
- 2012
- Review time
- 12 weeks
- DOI prefix
10.20892
ISSN
- 2095-3941
Frequently asked questions
Is Cancer Biology & Medicine peer-reviewed?
Does Cancer Biology & Medicine charge an article processing charge (APC)?
What subjects does Cancer Biology & Medicine publish?
What languages does Cancer Biology & Medicine accept?
What is the ISSN of Cancer Biology & Medicine?
2095-3941 (print).